Intuitive Surgical reported strong first-quarter results with 23% revenue growth, expanded margins, and earnings per share surpassing estimates by $0.39. The company raised its procedure growth forecast to 13.5%-15.5% and gross margin guidance to 67.5%-68.5%, despite facing cost inflation and softness in key markets like China and Japan. While risks remain from healthcare capital expenditure sensitivity and regional headwinds, Intuitive Surgical's market leadership and recurring revenue model support a positive outlook. The analyst maintains a 'Buy' rating with a $584.50 price target, expecting continued margin and free cash flow growth.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
